Article Details

Target Price Boosted 400% on Biopharma Co. - Streetwise Reports

Retrieved on: 2022-12-27 18:22:03

Tags for this article:

Click the tags to see associated articles and topics

Target Price Boosted 400% on Biopharma Co. - Streetwise Reports. View article details on hiswai:

Excerpt

As of ovember 30, 2022 neither the Firm nor its affiliates beneficially own 1% or more of any class of common equity securities of IMV Inc..

Article found on: www.streetwisereports.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up